FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4303946656> ?p ?o ?g. }

• W4303946656 endingPage "2521" @default.
• W4303946656 startingPage "2521" @default.
• W4303946656 abstract "(1) Purpose: To investigate the efficacy and safety of using PDT in the treatment of severe intraepithelial squamous lesions of the cervix and preinvasive cervical cancer associated with HPV in women of reproductive age. (2) Methods: The examination and treatment of 45 patients aged 22–49 years with morphologically confirmed HPV-associated cervical intraepithelial neoplasia of a severe degree (17 patients) and preinvasive cervical cancer (28 patients) were performed. All patients underwent PDT of the cervix using a chlorin e6 photosensitizer; after which, the affected areas of the cervix were evaluated using video and spectral fluorescence diagnostics. PDT effectiveness was assessed on the basis of colposcopy data, a cytological examination of exo- and endocervix and PAP test scrapings or the liquid cytology method, and polymerase chain reaction for HPV carriage 4 weeks after PDT, as well as on the basis of histological and immunohistochemical studies of biopsy materials 5 weeks after PDT. The expression levels of the Ki-67 and p16 markers in the affected areas of the cervix were also assessed. (3) Results. All patients included in the study tolerated the intravenous administration of the photosensitizer well, with no side effects or allergic reactions observed. In 88.2% of patients with CIN III/HSIL and in 85.7% of women with preinvasive cervical cancer, the effect of the treatment was noted after the first PDT procedure, while complete regression of the dysplasia foci was observed in 15 women (88.2%) with CIN III/HSIL and in 25 patients (89.3%) with preinvasive cervical cancer. Partial regression to the form of LSIL/CIN I was noted in two cases (11.8%) in the CIN III/HSIL group and in three cases (10.7%) in the group of patients with preinvasive cervical cancer. After PDT, a statistically significant decrease in the expression of the Ki-67 and p16 levels relative to the initial values was noted. (4) Conclusions. The results obtained indicate the high efficiency of PDT with intravenous administration of the chlorin photosensitizer for the treatment of intraepithelial lesions of the cervix with a selective effect on pathologically altered tissue. The use of this approach makes it possible to preserve the normal anatomical and functional characteristics of the cervix, which is especially important for maintaining the fertility of patients." @default.
• W4303946656 created "2022-10-10" @default.
• W4303946656 creator A5000496548 @default.
• W4303946656 creator A5010669106 @default.
• W4303946656 creator A5019388894 @default.
• W4303946656 creator A5020591494 @default.
• W4303946656 creator A5032877525 @default.
• W4303946656 creator A5043568026 @default.
• W4303946656 creator A5046062954 @default.
• W4303946656 creator A5074246786 @default.
• W4303946656 creator A5082026378 @default.
• W4303946656 creator A5085884329 @default.
• W4303946656 creator A5086551210 @default.
• W4303946656 creator A5091223989 @default.
• W4303946656 date "2022-10-09" @default.
• W4303946656 modified "2023-10-01" @default.
• W4303946656 title "Analysis of the Results of Severe Intraepithelial Squamous Cell Lesions and Preinvasive Cervical Cancer Phototheranostics in Women of Reproductive Age" @default.
• W4303946656 cites W1965679233 @default.
• W4303946656 cites W1987774610 @default.
• W4303946656 cites W2046591921 @default.
• W4303946656 cites W2072158805 @default.
• W4303946656 cites W2073773798 @default.
• W4303946656 cites W2111468096 @default.
• W4303946656 cites W2144175542 @default.
• W4303946656 cites W2213210908 @default.
• W4303946656 cites W2294877140 @default.
• W4303946656 cites W2489063059 @default.
• W4303946656 cites W2530258385 @default.
• W4303946656 cites W2552766341 @default.
• W4303946656 cites W2590947287 @default.
• W4303946656 cites W2744412017 @default.
• W4303946656 cites W2883297555 @default.
• W4303946656 cites W2962527820 @default.
• W4303946656 cites W2999417355 @default.
• W4303946656 cites W3080786716 @default.
• W4303946656 cites W3118909934 @default.
• W4303946656 cites W3120341836 @default.
• W4303946656 cites W3123904588 @default.
• W4303946656 cites W3128646645 @default.
• W4303946656 cites W3196524527 @default.
• W4303946656 cites W3216392961 @default.
• W4303946656 cites W4205114791 @default.
• W4303946656 cites W4225140983 @default.
• W4303946656 cites W4225316135 @default.
• W4303946656 cites W4283705051 @default.
• W4303946656 cites W3189296973 @default.
• W4303946656 doi "https://doi.org/10.3390/biomedicines10102521" @default.
• W4303946656 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36289783" @default.
• W4303946656 hasPublicationYear "2022" @default.
• W4303946656 type Work @default.
• W4303946656 citedByCount "1" @default.
• W4303946656 countsByYear W43039466562023 @default.
• W4303946656 crossrefType "journal-article" @default.
• W4303946656 hasAuthorship W4303946656A5000496548 @default.
• W4303946656 hasAuthorship W4303946656A5010669106 @default.
• W4303946656 hasAuthorship W4303946656A5019388894 @default.
• W4303946656 hasAuthorship W4303946656A5020591494 @default.
• W4303946656 hasAuthorship W4303946656A5032877525 @default.
• W4303946656 hasAuthorship W4303946656A5043568026 @default.
• W4303946656 hasAuthorship W4303946656A5046062954 @default.
• W4303946656 hasAuthorship W4303946656A5074246786 @default.
• W4303946656 hasAuthorship W4303946656A5082026378 @default.
• W4303946656 hasAuthorship W4303946656A5085884329 @default.
• W4303946656 hasAuthorship W4303946656A5086551210 @default.
• W4303946656 hasAuthorship W4303946656A5091223989 @default.
• W4303946656 hasBestOaLocation W43039466561 @default.
• W4303946656 hasConcept C121608353 @default.
• W4303946656 hasConcept C126322002 @default.
• W4303946656 hasConcept C142724271 @default.
• W4303946656 hasConcept C143998085 @default.
• W4303946656 hasConcept C2775894508 @default.
• W4303946656 hasConcept C2775934546 @default.
• W4303946656 hasConcept C2776117191 @default.
• W4303946656 hasConcept C2777343196 @default.
• W4303946656 hasConcept C2777740455 @default.
• W4303946656 hasConcept C2778220009 @default.
• W4303946656 hasConcept C29456083 @default.
• W4303946656 hasConcept C71924100 @default.
• W4303946656 hasConceptScore W4303946656C121608353 @default.
• W4303946656 hasConceptScore W4303946656C126322002 @default.
• W4303946656 hasConceptScore W4303946656C142724271 @default.
• W4303946656 hasConceptScore W4303946656C143998085 @default.
• W4303946656 hasConceptScore W4303946656C2775894508 @default.
• W4303946656 hasConceptScore W4303946656C2775934546 @default.
• W4303946656 hasConceptScore W4303946656C2776117191 @default.
• W4303946656 hasConceptScore W4303946656C2777343196 @default.
• W4303946656 hasConceptScore W4303946656C2777740455 @default.
• W4303946656 hasConceptScore W4303946656C2778220009 @default.
• W4303946656 hasConceptScore W4303946656C29456083 @default.
• W4303946656 hasConceptScore W4303946656C71924100 @default.
• W4303946656 hasIssue "10" @default.
• W4303946656 hasLocation W43039466561 @default.
• W4303946656 hasLocation W43039466562 @default.
• W4303946656 hasLocation W43039466563 @default.
• W4303946656 hasOpenAccess W4303946656 @default.
• W4303946656 hasPrimaryLocation W43039466561 @default.
• W4303946656 hasRelatedWork W1981773266 @default.
• W4303946656 hasRelatedWork W2089141669 @default.

• next